Cybin Inc.
Cybin Inc. (CYBN.NE) PE Ratio — Current & Historical Data
Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.
cybn.ne · pe ratio · data through Mar 31, 2025
Core PE Ratio Metrics
Trailing 12 months · TTMThe price-to-earnings (P/E) ratio for Cybin Inc. (CYBN.NE) measures how much investors pay for each dollar of the company's trailing earnings. CYBN.NE's current PE ratio of N/A is calculated by dividing its stock price of $5.70 by its TTM earnings per share of -$2.93.
Source: FMP · /ratios-ttm · /analyst-estimates · 2025-03-31
PE Ratio History
2017 – 2025 · Annual▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare (Annual)
PE Ratio vs Peers
Biotechnology · 6 peers · Annual PE| Company | Market Cap | PE (Annual) | vs Avg | EPS (TTM) |
|---|---|---|---|---|
Cybin Inc.You CYBN.NE | $138M | N/A | — | -$2.93 |
 CareRx Corporation CRRX.TO | $205M | 9.17x | -7.6% | $0.42 |
 Medical Facilities Corporation DR.TO | $317M | 10.68x | +7.6% | $1.08 |
 Eupraxia Pharmaceuticals Inc. EPRX.TO | $305M | N/A | — | -$0.98 |
 Fennec Pharmaceuticals Inc. FRX.TO | $356M | N/A | — | -$0.36 |
 Helix BioPharma Corp. HBP.TO | $117M | N/A | — | -$0.09 |
 Jushi Holdings Inc. JUSH.CN | $144M | N/A | — | -$0.35 |
Industry Average 2 peers with valid PE | — | 9.93x | baseline | — |
* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio
Annual PE Ratio History
| Fiscal Year End | PE Ratio | EPS (TTM) | YoY Change | PE vs Max |
|---|---|---|---|---|
2025-03-31Latest FY2025 | — | $-0.61 | — | |
2024-03-31 FY2024 | — | $-9.50 | — | |
2023-03-31 FY2023 | — | $-0.26 | — | |
2022-03-31 FY2022 | — | $-0.40 | — | |
2021-03-31 FY2021 | — | $-0.32 | — | |
2020-03-31 FY2020 | — | $-0.05 | — | |
2019-07-31 FY2019 | — | $-0.01 | — | |
2018-07-31 FY2018 | — | $-0.00 | — | |
2017-07-31 FY2017 | — | $-0.01 | — |
▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare · Zero extra API
About PE Ratio & Methodology
The price-to-earnings (P/E) ratio for Cybin Inc. (CYBN.NE) measures how much investors pay for each dollar of the company's trailing earnings. CYBN.NE's current PE ratio of N/A is calculated by dividing its stock price of $5.70 by its TTM earnings per share of -$2.93.
Frequently asked questions
CYBN.NE pe ratio · 6 questionsCYBN.NE's current PE ratio is N/A as of 2026-06-08, based on a stock price of $5.70 and TTM EPS of -$2.93. Data sourced from Financial Modeling Prep via CYBN.NE's SEC 10-K and 10-Q filings.
▸ Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · Cybin Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-08